Director, President and COO · Bicara Therapeutics Inc. · Common Stock
Side
SELL
Value
$144K
Shares
8,000
Price
$18.05
Executed
Nov 21, 2025
Disclosed
Nov 25, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Nov 21 executedNov 25, 2025 disclosed
BCAX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Cohlhepp Ryan filed this Form 4 reporting a open-market sale of BCAX on Nov 21, 2025. It became public on Nov 25, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and COO
Cohlhepp Ryancik:0002034665
Issuer
Bicara Therapeutics Inc.cik:0002023658
Revision history · 0
No field has changed since this record was first ingested.
